SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.06.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Straumann hold | Vontobel Research | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 01.06.12 | Lonza hold | Vontobel Research | |
| 31.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Novartis outperform | Credit Suisse Group | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 25.05.12 | Newron PharmaceuticalsAz. kaufen | Hanseatischer Börsendienst | |
| 23.05.12 | Sonova buy | Vontobel Research | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 22.05.12 | Sonova neutral | Sarasin Research | |
| 22.05.12 | Sonova buy | Vontobel Research | |
| 21.05.12 | Straumann hold | Vontobel Research | |
| 18.05.12 | Sonova equal-weight | Morgan Stanley | |
| 18.05.12 | Novartis hold | Vontobel Research | |
| 17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 16.05.12 | Straumann hold | Vontobel Research | |
| 15.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 10.05.12 | Straumann hold | Vontobel Research | |
| 08.05.12 | Lonza kaufen | Die Actien-Börse | |
| 07.05.12 | Lonza hold | Vontobel Research | |
| 04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
| 04.05.12 | Novartis buy | UBS AG | |
| 04.05.12 | Lonza neutral | Sarasin Research | |
| 04.05.12 | Lonza underperform | Cheuvreux SA | |
| 04.05.12 | Lonza hold | Vontobel Research | |
| 03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.05.12 | Novartis hold | Vontobel Research | |
| 30.04.12 | Novartis hold | Vontobel Research | |
| 26.04.12 | Straumann hold | Vontobel Research | |
| 26.04.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.04.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) |